Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-20

Clinical Trial Update: Analgesic Effect of Parecoxib Versus Morphine in SCD Patients Presenting to the Emergency Department [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating analgesia with parecoxib versus morphine in emergency department patients with sickle cell disease experiencing a crisis; the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine (morphine)
  • Parecoxib (Dynastat) (parecoxib)

Snippet

Sponsor: Oman Medical Speciality Board | Conditions: Sickle-Cell Disease with Crisis | Phase 3 | Status: NOT_YET_RECRUITING